Yahoo France Recherche Web

Ouvrir une session

Résultats de recherche

  1. finance.yahoo.com › news › prometheus-rxdx-stockPrometheus (RXDX) Stock Surges 70% on Buyout Offer From Merck

    17 avr. 2023 · Prometheus (RXDX) is set to be acquired by Merck for $11 billion, adding Prometheus' lead product candidate, PRA023, to Merck's portfolio. Prometheus' stock is up 70%.

  2. fr.finance.yahoo.com › quote › RXDXRXDX - Prometheus Biosciences, Inc. - Yahoo Finance

    Recherchez les dernières actualités, les cotations boursières et l’historique Prometheus Biosciences, Inc. (RXDX), ainsi que d’autres informations essentielles qui vous aideront dans vos...

  3. fr.finance.yahoo.com › news › merck-completesMerck Completes Acquisition of Prometheus Biosciences, Inc.

    16 juin 2023 · RAHWAY, N.J., June 16, 2023--Merck Completes Acquisition of Prometheus Biosciences, Inc.

  4. finance.yahoo.com › news › prometheus-biosciencesPrometheus Biosciences Reports First Quarter 2023 Financial ...

    9 mai 2023 · Prometheus Biosciences, Inc. is a clinical-stage biotechnology company pioneering a precision medicine approach for the discovery, development, and commercialization of novel therapeutics for the...

  5. finance.yahoo.com › news › merck-stage-talks-acquireMerck to build out immunology presence with $11 billion ...

    17 avr. 2023 · (Reuters) -Merck & Co said on Sunday it will buy Prometheus Biosciences Inc for about $10.8 billion, picking up a promising experimental treatment for ulcerative colitis and Crohn's disease and...

  6. fr.news.yahoo.com › alien-covenant-plus-gore-et"Alien : Covenant", plus gore et moins pénible que "Prometheus"

    7 mai 2017 · Cinq ans après Prometheus, premier épisode de son prequel à la saga Alien, Ridley Scott dégaine Covenant, le second film de sa trilogie annoncée. Et là où le volet précédent, trop plat, trop...

  7. fr.finance.yahoo.com › news › prometheus-biosciencesPrometheus Biosciences, Inc. (RXDX) Reports Q1 Loss, Tops ...

    9 mai 2023 · Prometheus Biosciences, Inc. (RXDX) delivered earnings and revenue surprises of 6.52% and 74.57%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for...